Catalog Home Page

Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease

Adams, L.A., White, S.W., Marsh, J.A., Lye, S.J., Connor, K.L., Maganga, R., Ayonrinde, O.T., Olynyk, J.K., Mori, T.A., Beilin, L.J., Palmer, L.J., Hamdorf, J.M. and Pennell, C.E. (2013) Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology, 57 (2). pp. 590-600.

Free to read: http://dx.doi.org/10.1002/hep.26184
*No subscription required

Abstract

Genetic factors account for a significant proportion of the phenotypic variance of nonalcoholic fatty liver disease (NAFLD); however, very few predisposing genes have been identified. We aimed to (1) identify novel genetic associations with NAFLD by performing a genome-wide association study (GWAS), and (2) examine the biological expression of the strongest genetic associations in a separate cohort. We performed GWAS of a population-based cohort (Raine Study) of 928 adolescents assessed for NAFLD by ultrasound at age 17. Expression of genes with single nucleotide polymorphisms (SNPs) that were associated with NAFLD at a significance level of P < 10−5 was examined in adults with NAFLD and controls by quantifying hepatic messenger RNA (mRNA) expression and serum levels of protein. After adjustment for sex and degree of adiposity, SNPs in two genes expressed in liver were associated with NAFLD adolescents: group-specific component (GC) (odds ratio [OR], 2.54; P = 1.20 × 10−6) and lymphocyte cytosolic protein-1 (LCP1) (OR, 3.29; P = 2.96 × 10−6). SNPs in two genes expressed in neurons were also associated with NAFLD: lipid phosphate phosphatase-related protein type 4 (LPPR4) (OR, 2.30; P = 4.82 × 10−6) and solute carrier family 38 member 8 (SLC38A8) (OR, 3.14; P = 1.86 × 10−6). Hepatic GC mRNA was significantly reduced (by 83%) and LCP1 mRNA was increased (by 300%) in liver biopsy samples from patients with NAFLD compared to controls (P < 0.05). Mean serum levels of GC protein were significantly lower in patients with NAFLD than controls (250 ± 90 versus 298 ± 90, respectively; P = 0.004); GC protein levels decreased with increasing severity of hepatic steatosis (P < 0.01). Conclusion: The association between GC and LCP1 SNPs and NAFLD as well as altered biological expression implicate these genes in the pathogenesis of NAFLD.

Publication Type: Journal Article
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Publisher: John Wiley & Sons Inc.
Copyright: © 2012 American Association for the Study of Liver Diseases
URI: http://researchrepository.murdoch.edu.au/id/eprint/17060
Item Control Page Item Control Page